The aim of this study was to examine the over-expression of HER-2/neu in patients suffering from gastric adenocarcinoma in Babol, Iran and to evaluate its probable correlation with clinico-pathological findings. This evidence concerns the gene ERBB2 and gastric adenocarcinoma.